MCKMcKesson
$895.39-1.39%Real quote · delayedDrug distributionHealthcare services & payers · 7 peers →🏛️ Company factsSEC filings + FINRA official data
Annual revenue $403.4B · latest quarter up 7.7% YoY · profitable (FY net income $4.8B) · short activity above its recent average — bears adding.
FY revenue
$403.4B
2026-03
Latest Q YoY
+7.7%
Gross margin
3.6%
FY net income
$4.8B
Diluted EPS
$38.55
Short volume
70.5%
20d avg 54.6% · shorts building
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-04-30passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-03-27passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 70/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$9.93 vs $9.44+5.19%
- Mar 2026$11.69 vs $11.56+1.12%
- Dec 2025$9.34 vs $9.31+0.32%
- Sep 2025$9.86 vs $8.92+10.54%
The takeaway
This company habitually beats by +4.3% — the next report has to clear that bar to count as good news.
Analyst estimates, not our forecast · not investment advice
What's moving this stock lately
No recent news affecting this stock
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
11 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →